Trial Parameters
Condition Cardiovascular Diseases
Sponsor University of Calgary
Study Type OBSERVATIONAL
Phase N/A
Enrollment 45,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-08
Completion 2025-08
Interventions
Diagnostic testing performed as per routine care
Brief Summary
A multi-site, multi-modality prospective observational clinical outcomes study focussed on the development of phenotype-dirven risk prediction modelling in patients with known or suspected cardiovascular disease.
Eligibility Criteria
Inclusion Criteria: * All patients referred for hospital-based cardiac imaging services Exclusion Criteria: * Failure or provide informed consent
Related Trials
NCT05943821
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
View Trial →
NCT04055428
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
View Trial →
NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
View Trial →